肝细胞癌立体定向体部放疗后肝实质变化的磁共振弹性成像与扩散加权成像检测
回顾性评估22例接受SBRT的HCC患者和27例接受其他局部治疗对照,用MRE和DWI测量放疗前后肝实质硬度与ADC值。>30 Gy剂量区肝硬度(4.05 vs 4.85 kPa)和ADC值(1.10 vs 1.40×10⁻³ s/mm²)均显著升高(p<0.05);≤30 Gy区及对照组无显著差异。结论认为MRE和DWI可用于检测SBRT所致肝实质改变。
要点
- SBRT后>30 Gy剂量区肝硬度及ADC值较治疗前显著升高。
- ≤30 Gy剂量区ADC值无显著差异,肝硬度仅一名阅片者显示显著升高。
- 对照组治疗前后肝硬度及ADC值均无显著差异。
核心结论
- MRE和DWI可用于检测SBRT诱导的肝实质改变。
研究设计与样本
- 回顾性研究,纳入22例接受SBRT的HCC成年患者和27例接受非SBRT局部治疗的对照,测量SBRT前后肝实质MRE硬度和DWI的ADC值,ROI置于>30 Gy和≤30 Gy两个剂量分布区,对照组画一个ROI。
关键影像表现/征象
- SBRT后>30 Gy剂量区肝硬度较治疗前升高(4.05 vs 4.85 kPa,p<0.05)。
- SBRT后>30 Gy剂量区ADC值较治疗前升高(1.10 vs 1.40×10⁻³ s/mm²,p<0.05)。
- ≤30 Gy剂量区肝硬度在一名阅片者显示显著升高(p=0.033),另一名阅片者未显示显著差异(p=0.085)。
- ≤30 Gy剂量区ADC值两名阅片者均显示SBRT前后无显著差异(p>0.05)。
- 对照组治疗前后肝硬度及ADC值均无显著差异(p>0.05)。
诊断标准与关键数值
- 以ROI置于辐射剂量分布>30 Gy和≤30 Gy两个区域进行测量分析。
- 采用Wilcoxon配对符号秩检验比较SBRT前后MRE肝硬度与DWI的ADC值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Stereotactic body radiotherapy (SBRT) is a local treatment option for hepatocellular carcinoma (HCC). SBRT-induced focal reactions on the liver parenchyma have not been thoroughly evaluated using quantitative magnetic resonance imaging (MRI).
PURPOSE: To quantitatively evaluate liver parenchymal changes caused by SBRT for HCC using magnetic resonance elastography (MRE) and diffusion-weighted imaging (DWI).
METHOD: We retrospectively evaluated 22 adult patients who received SBRT for HCC and 27 who received locoregional therapy other than SBRT (controls). Liver stiffness by MRE and apparent diffusion coefficient (ADC) values by DWI of the liver parenchyma were measured before and after SBRT. Regions of interest (ROIs) were drawn on the two areas of radiation dose distribution levels, > 30 Gy and ≤ 30 Gy; a ROI was drawn in the control group. The two indices were compared before and after SBRT using a Wilcoxon matched-pairs signed-rank test.
RESULTS: Liver stiffness and ADC values were significantly increased after SBRT in the dose areas of > 30 Gy compared with those before SBRT (4.05 vs 4.85 kPa; p < 0.05 in liver stiffness, and 1.10 vs 1.40 ×10-3 s/mm2; p < 0.05 in ADC values). In the dose area of ≦ 30 Gy, liver stiffness showed a significant increase in one reader (p = 0.033) but not in another reader (p = 0.085); ADC value showed no significant difference before and after SBRT as per both readers (p > 0.05). The control group demonstrated no significant differences before and after treatment (p > 0.05).
CONCLUSION: MRE and DWI can be used to detect SBRT-induced liver parenchymal changes.
引用
- Omiya Y, Morisaka H, Matsuda M, et al. Liver parenchymal changes detected by MR elastography and diffusion-weighted imaging after stereotactic body radiotherapy for hepatocellular carcinoma. Abdom Radiol (NY). 2023. PMID: 37542553. doi:10.1007/s00261-023-03995-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。